Metoclopramide Hydrochloride
- Product NDC
- 68071-3031
- 11-digit product format
- 680713031
- Labeler code
- 68071
- Product ID
- 68071-3031_49dcda70-98b4-07a1-e054-00144ff8d46c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Metoclopramide Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals, Inc.
- Application
- ANDA071250
- Marketing category
- ANDA
- Marketing start
- 2011-08-22
- Marketing end
- 0000-00-00
- Substance
- METOCLOPRAMIDE HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Dopamine D2 Antagonists [MoA],Dopamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-3031-2 | 2020-05-05 | C162847 | 48780-1 | 9d75b9d0-d94e-f424-e053-dadaa90a57ce | 49dce96b-bac0-3673-e054-00144ff88e88 |
| 68071-3031-3 | 2020-05-05 | C162847 | 48780-1 | 9d75b9d0-d94e-f424-e053-dadaa90a57ce | 49dce96b-bac0-3673-e054-00144ff88e88 |
| 68071-3031-6 | 2020-05-05 | C162847 | 48780-1 | 9d75b9d0-d94e-f424-e053-dadaa90a57ce | 49dce96b-bac0-3673-e054-00144ff88e88 |
| 68071-3031-9 | 2020-05-05 | C162847 | 48780-1 | 9d75b9d0-d94e-f424-e053-dadaa90a57ce | 49dce96b-bac0-3673-e054-00144ff88e88 |
| 68071-3031-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-d94e-f424-e053-dadaa90a57ce | 49dce96b-bac0-3673-e054-00144ff88e88 |
| 68071-3031-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-d94e-f424-e053-dadaa90a57ce | 49dce96b-bac0-3673-e054-00144ff88e88 |
| 68071-3031-6 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-d94e-f424-e053-dadaa90a57ce | 49dce96b-bac0-3673-e054-00144ff88e88 |
| 68071-3031-9 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-d94e-f424-e053-dadaa90a57ce | 49dce96b-bac0-3673-e054-00144ff88e88 |